This tumor-suppressive function also extends to enhancing treatment efficacy, as nuclear Cdk5 has been shown to promote apoptosis and attenuate chemoresistance via the DP1–E2F1 axis [175]. This evidence concerns the gene CDK5 and neoplasm.